$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 30 Aug 2016 | 27414 | In Stock
Related Topics: Clinical Trials

Introduction

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials 19

    Clinical Trials by Phase in E7 Countries 21

    Clinical Trials by Phase 22

    In Progress Trials by Phase 23

    Clinical Trials by Trial Status 24

    Clinical Trials by End Point Status 25

    Subjects Recruited Over a Period of Time 26

    Clinical Trials by Sponsor Type 27

    Prominent Sponsors 28

    Top Companies Participating in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials 29

    Prominent Drugs 31

    Clinical Trial Profile Snapshots 32

    Appendix 80

    Abbreviations 80

    Definitions 80

    Research Methodology 81

    Secondary Research 81

    About GlobalData 82

    Contact Us 82

    Disclaimer 82

    Source 83

List Of Tables
in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

List of Tables

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Region, 2016* 6

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 10

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14

Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, G7 Countries (%), 2016* 16

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18

Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, E7 Countries (%), 2016* 20

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Phase, 2016* 22

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31

List Of Figures, Charts and Diagrams
in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

List of Figures

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 10

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14

Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, G7 Countries (%), 2016* 15

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18

Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, E7 Countries (%), 2016* 19

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31

GlobalData Methodology 81

Additional Details

Publisher

Global Data

Publisher Information

Reference

27414 | GDHC3730CTIDB

Number of Pages

83

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016
Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016SummaryGlobalData'...
16 Mar 2016 by Global Data USD $2,500 More Info
China Peripheral Vascular Devices Market Outlook to 2021
China Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, China Periph...
05 Feb 2016 by Global Data USD $2,500 More Info
United States Peripheral Vascular Devices Market Outlook to 2021
United States Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, Unit...
01 Feb 2016 by Global Data USD $2,500 More Info
United Kingdom Peripheral Vascular Devices Market Outlook to 2021
United Kingdom Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, Uni...
01 Feb 2016 by Global Data USD $2,500 More Info
France Peripheral Vascular Devices Market Outlook to 2021
France Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, France Peri...
01 Feb 2016 by Global Data USD $2,500 More Info
Germany Peripheral Vascular Devices Market Outlook to 2021
Germany Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, Germany Pe...
01 Feb 2016 by Global Data USD $2,500 More Info
Italy Peripheral Vascular Devices Market Outlook to 2021
Italy Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, Italy Periph...
01 Feb 2016 by Global Data USD $2,500 More Info
Spain Peripheral Vascular Devices Market Outlook to 2021
Spain Peripheral Vascular Devices Market Outlook to 2021SummaryGlobalData’s new report, Spain Periph...
01 Feb 2016 by Global Data USD $2,500 More Info
Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016
Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical tria...
20 Jan 2016 by Global Data USD $2,500 More Info
PharmaPoint: Peripheral Artery Disease - Global Drug Forecast and Market Analysis to 2024
PharmaPoint: Peripheral Artery Disease - Global Drug Forecast and Market Analysis to 2024SummaryIn t...
01 Oct 2015 by Global Data USD $10,995 More Info

This report is published by Global Data

Download Free Report Summary PDF

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...